Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Vaitkus, S. Lavinskiene, K. Bieksiene, J. Jeroch, R. Sakalauskas (Kaunas, Lithuania). Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD. Eur Respir J 2012; 40: Suppl. 56, 793

Member's Comments

No comment yet.

Related content which might interest you: Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Increased production of reactive oxygen species of systemic PMN from COPD patients in comparison to healthy controls Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Alterations in oxygen consumption during acute exacerbations of COPD Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018 Cytokine-mediated reactive oxygen species hyperproduction in the airway inflammation of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003 Active oxigen species generation by leukocytes in infants with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006 Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Apocynin reduces reactive oxygen species generation in airways of asthmatics Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Influence of AECOPD to ROS production in neutrophils Source: Annual Congress 2011 - COPD: human studies Year: 2011 Reactive oxygen species generation and exhaled nitric oxide in atopic mild bronchial asthma in exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005 Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Cytokine profile of blood and sputum at infectional COPD exacerbation Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2003; 22: 457-461 Year: 2003 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020